Monoclonal Antibodies as Long-Acting Products: What Are We Learning From Human Immunodeficiency Virus (HIV) and Coronavirus Disease 2019 (COVID-19)? is a research paper published in Clinical Infectious Diseases (2022). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P30 AI124414
Harvard University
Grant: P30 AI060354
Centers for AIDS Research
Grant: UM1 AI164565
BEAT-HIV
Grant: UM1 AI12662
Boston HIV Clinical Trials Unit
Grant: UM1 AI069412
Boston HIV Clinical Trials Unit
Grant: U01 AI35940
Boston HIV Clinical Trials Unit
Grant: R01 AI157854
Cure
NIH HHS
FWCI
0.51
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals